Breast Conserving Surgery and Sentinel Lymph Node Biopsy in Locally Advanced Breast Cancer: Single Center Experience

Basit Öğe Kaydı
dc.authoridCosar, Rusen/0000-0002-7953-8887
dc.authoridCosar, Rusen/0000-0002-7953-8887
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authorwosidCosar, Rusen/AAC-4045-2020
dc.authorwosidCosar, Rusen/GQP-7875-2022
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.contributor.authorSezer, Atakan
dc.contributor.authorAlas, Rusen Cosar
dc.contributor.authorCicin, Irfan
dc.contributor.authorHoscoskun, Zeki
dc.contributor.authorTuncbilek, Nermin
dc.date.accessioned2024-06-12T10:55:13Z
dc.date.available2024-06-12T10:55:13Z
dc.date.issued2011
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective: Patients with locally advanced breast cancer may undergo breast conserving surgery after neoadjuvant chemotherapy. The aim of the study is to evaluate the results of locally advanced breast cancer patients who underwent breast conserving surgery, axillary dissection and sentinel lymph node biopsy in a single center. Material and Methods: 12 patients with locally advanced breast cancer stage IIIA/IIIB were included in the study between 2002-2009. The patients were given anthracycline-based regimen before surgery. Patients underwent breast conserving surgery, axillary dissection, and sentinel lymph node biopsy followed by radiotherapy. Results: There were five patients in stage IIIA, six in stage IIIB, and one in stage IIIC. Patients had received 3-6 regimen of FAC/FEC. Eight had partial and four had complete response. Five positive axilla were detected. The median value of the lymph nodes was 12 (n:8-19). Five patients underwent sentinel lymph node biopsy. The biopsy has failed in one patient and the median value of dissected sentinel node was 3.5 (n:3-4). Locoregional recurrence was not observed in any patients. The mean follow-up of the patients was 29.8 months and median time was 16 (n:2-80) months. Of the 12 patients 10 are alive and 2 were deceased. Conclusion: In selected locally advanced patients, breast conserving surgery and sentinel lymph node biopsy may be applied by a multidisciplinary approach, and excellent success may be achieved in those patients as in early breast cancer patients.en_US
dc.identifier.doi10.5174/tutfd.2010.03298.1
dc.identifier.endpage142en_US
dc.identifier.issn2146-3123
dc.identifier.issn2146-3131
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-79960983535en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage138en_US
dc.identifier.urihttps://doi.org/10.5174/tutfd.2010.03298.1
dc.identifier.urihttps://hdl.handle.net/20.500.14551/19342
dc.identifier.volume28en_US
dc.identifier.wosWOS:000293360000006en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofBalkan Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBreast Canceren_US
dc.subjectLocally Advanced Stageen_US
dc.subjectBreast Conserving Surgeryen_US
dc.subjectSentinel Lymph Node Biopsyen_US
dc.subjectComparing Total Mastectomyen_US
dc.subject20-Year Follow-Upen_US
dc.subjectNeoadjuvant Chemotherapyen_US
dc.subjectPreoperative Chemotherapyen_US
dc.subjectPrognostic-Significanceen_US
dc.subjectConservationen_US
dc.subjectIrradiationen_US
dc.subjectLumpectomyen_US
dc.subjectTherapyen_US
dc.subjectTumoren_US
dc.titleBreast Conserving Surgery and Sentinel Lymph Node Biopsy in Locally Advanced Breast Cancer: Single Center Experienceen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu